These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 21721593

  • 1. Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
    Junge W, Mellinger U, Parke S, Serrani M.
    Clin Drug Investig; 2011; 31(8):573-584. PubMed ID: 21721593
    [Abstract] [Full Text] [Related]

  • 2. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.
    Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
    [Abstract] [Full Text] [Related]

  • 3. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
    Lete I, Chabbert-Buffet N, Jamin C, Lello S, Lobo P, Nappi RE, Pintiaux A.
    Eur J Contracept Reprod Health Care; 2015 Nov; 20(5):329-43. PubMed ID: 26007631
    [Abstract] [Full Text] [Related]

  • 4. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
    Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W.
    Drugs R D; 2011 Nov; 11(2):159-70. PubMed ID: 21679006
    [Abstract] [Full Text] [Related]

  • 5. Effect of dienogest-containing oral contraceptives on lipid metabolism.
    Wiegratz I, Lee JH, Kutschera E, Bauer HH, von Hayn C, Moore C, Mellinger U, Winkler UH, Gross W, Kuhl H.
    Contraception; 2002 Mar; 65(3):223-9. PubMed ID: 11929644
    [Abstract] [Full Text] [Related]

  • 6. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism.
    Ågren UM, Anttila M, Mäenpää-Liukko K, Rantala ML, Rautiainen H, Sommer WF, Mommers E.
    Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):444-57. PubMed ID: 22066891
    [Abstract] [Full Text] [Related]

  • 7. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
    Davis SR, Bitzer J, Giraldi A, Palacios S, Parke S, Serrani M, Mellinger U, Nappi RE.
    J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
    [Abstract] [Full Text] [Related]

  • 8. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H.
    Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
    [Abstract] [Full Text] [Related]

  • 9. Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
    Kangasniemi MH, Arffman RK, Haverinen A, Luiro K, Hustad S, Heikinheimo O, Tapanainen JS, Piltonen TT.
    Contraception; 2022 Dec; 116():59-65. PubMed ID: 36084710
    [Abstract] [Full Text] [Related]

  • 10. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
    Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, Kuhl H.
    Contraception; 2003 Jan; 67(1):25-32. PubMed ID: 12521654
    [Abstract] [Full Text] [Related]

  • 11. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Raps M, Rosendaal F, Ballieux B, Rosing J, Thomassen S, Helmerhorst F, van Vliet H.
    J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
    [Abstract] [Full Text] [Related]

  • 12. Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
    Kangasniemi MH, Arffman RK, Joenväärä S, Haverinen A, Luiro K, Tohmola T, Renkonen R, Heikinheimo O, Tapanainen JS, Piltonen TT.
    Hum Reprod; 2023 Jan 05; 38(1):89-102. PubMed ID: 36416543
    [Abstract] [Full Text] [Related]

  • 13. Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
    Petraglia F, Parke S, Serrani M, Mellinger U, Römer T.
    Int J Gynaecol Obstet; 2014 Jun 05; 125(3):270-4. PubMed ID: 24713413
    [Abstract] [Full Text] [Related]

  • 14. Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.
    Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, Kuhl H.
    Contraception; 2003 May 05; 67(5):361-6. PubMed ID: 12742558
    [Abstract] [Full Text] [Related]

  • 15. Estradiol Valerate in COC Has More Favorable Inflammatory Profile Than Synthetic Ethinyl Estradiol: A Randomized Trial.
    Kangasniemi MH, Haverinen A, Luiro K, Hiltunen JK, Komsi EK, Arffman RK, Heikinheimo O, Tapanainen JS, Piltonen TT.
    J Clin Endocrinol Metab; 2020 Jul 01; 105(7):. PubMed ID: 32303765
    [Abstract] [Full Text] [Related]

  • 16. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO, Endrikat J, Düsterberg B, Schmidt W, Gerlinger C, Wessel J, Goldstein H, Jespersen J.
    Contraception; 2005 Feb 01; 71(2):111-7. PubMed ID: 15707560
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
    Douxfils J, Klipping C, Duijkers I, Kinet V, Mawet M, Maillard C, Jost M, Rosing J, Foidart JM.
    Contraception; 2020 Dec 01; 102(6):396-402. PubMed ID: 32956694
    [Abstract] [Full Text] [Related]

  • 18. An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables.
    Winkler UH, Röhm P, Höschen K.
    Contraception; 2010 May 01; 81(5):391-400. PubMed ID: 20399945
    [Abstract] [Full Text] [Related]

  • 19. Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
    Haverinen AH, Luiro KM, Szanto T, Kangasniemi MH, Hiltunen L, Sainio S, Piltonen TT, Lassila R, Tapanainen JS, Heikinheimo O.
    Acta Obstet Gynecol Scand; 2022 Oct 01; 101(10):1102-1111. PubMed ID: 35909329
    [Abstract] [Full Text] [Related]

  • 20. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J, Assmann A, Möhner S, Minh TD.
    J Fam Plann Reprod Health Care; 2010 Jul 01; 36(3):123-9. PubMed ID: 20659364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.